Latest Exploration Partnerships News

Racura Oncology has secured governance approval to launch its Phase 1 HARNESS-1 trial, testing RC220 alongside osimertinib in EGFR-mutated non-small cell lung cancer patients. This milestone sets the stage for a potentially pivotal new approach to overcoming resistance in lung cancer treatment.

H3 Energy has appointed LAB Energy Advisors to spearhead farm-in talks for its Alinya project, a vast and underexplored oil and gas prospect in South Australia’s Officer Basin. The move aims to accelerate partner engagement ahead of drilling a potentially game-changing well.

AngloGold Ashanti has begun exploration drilling on Matsa Resources’ Lake Carey tenement, signalling strong interest in the region and setting the stage for 2026 exploration activities.

EcoGraf Limited has marked significant progress in its Epanko Graphite Project financing and expansion plans, while initiating a strategic gold farm-in agreement with AngloGold Ashanti in Tanzania.

Resonance Health has reported record half-year revenue and strong progress in clinical trials, alongside promising new technology deployments set to enhance its global footprint.

Pilot Energy has made significant strides in Q4 2025 with the launch of a modular data centre joint venture, progress on a hybrid solar and battery project, and advancement of offshore gas exploration partnerships, supported by substantial new financing.

First Graphene Limited has reported a landmark quarter with a 156% surge in customer cash receipts and a major industrial-scale production of graphene-enhanced cement, signalling a pivotal step in commercialising graphene across multiple sectors.

Patronus Resources has reported robust exploration results across Western Australia and the Northern Territory, highlighting significant gold and uranium discoveries that promise to expand its resource base. With a strong cash position, the company is well placed to advance its projects in 2026.

Diatreme Resources has completed the sale of its Clermont Copper/Gold Project, retaining a significant stake in the new ASX-listed Moonlight Resources, while progressing metallurgical improvements and environmental approvals on its critical minerals projects.

Racura Oncology reported a transformative quarter with key scientific discoveries, expanded clinical programs, and a robust cash position of $20.94 million, setting the stage for pivotal cancer trials in 2026.

Syrah Resources delivered a record quarter with a 34% rise in natural graphite production and advancing anode material qualification at its Vidalia facility, while navigating evolving US trade policies that could reshape its market dynamics.

Po Valley Energy Limited reported steady gas production and strong cashflows from its Podere Maiar-1 facility during the December 2025 quarter, while completing a major 3D geophysical survey to support future development.